Cyclic derivatives as modulators of chemokine receptor activity
US7087604B2 · kind B2 · utility
13Cited by
2References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 7, 2003 |
| Grant date | Aug 8, 2006 |
| Priority date | — |
| Expiry date | May 8, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present application describes modulators of MCP-1 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of rheumatoid arthritis, multiple sclerosis, atherosclerosis, asthma, restinosis, organ transplantation, and cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.